Advertisement

Picture BioM Forum Translational Medicine 2018 Würzburg Germany 600x60px

News > All

Please find below news from the United Kingdom (Great Britain) and the Republic of Ireland as well as about organisations from these countries.

Total search results: 4234 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 8 9 10 ... 41 42 43  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Bruker Corporation. (4/21/17). "Press Release: Bruker Introduces New Clinical Microbiology Assays and Kits at ECCMID". Vienna. 2017-04-21
Advent France Biotechnology S.A.S.. (4/20/17). "Press Release: Advent France Biotechnology Announces Its First Life Sciences Dedicated Seed-Fund with a First Closing at €64.75M (USD68.5M)". Paris. 2017-04-20
Bicycle Therapeutics Ltd.. (4/20/17). "Press Release: Bicycle Therapeutics Announces a Candidate Preclinical Milestone in Its Ophthalmology Alliance with Thrombogenics". Cambridge, MA & Cambridge. 2017-04-20
Curetis N.V.. (4/20/17). "Press Release: Curetis’ Unyvero Intra-Abdominal Infection (IAI) Cartridge Receives CE Marking". Amsterdam & Holzgerlingen. 2017-04-20
Evolva Holding S.A.. (4/20/17). "Press Release: Gerard Hoetmer, Formerly at Unilever and Corbion, Proposed to Succeed Sir Tom McKillop as Evolva Chairman". Switzerland. 2017-04-20
OBN (UK) Ltd.. (4/20/17). "Press Release: OBN Appoints New Director to Enhance Board Expertise". Abingdon. 2017-04-20
Redx Pharma plc. (4/20/17). "Press Release: Appointment of Chairman". 2017-04-20
Oxford Cancer Biomarkers Ltd.. (4/19/17). "Press Release: Oxford Cancer Biomarkers Announces Strategic Collaboration with My-BioMed Biotechnology Co. Ltd.". Oxford. 2017-04-19
Cobra Biologics Ltd.. (4/18/17). "Press Release: Cobra Biologics Embarks On £15m (165m SEK) Gene Therapy Manufacturing Operations Expansion". Keele & Matfors & Södertälje. 2017-04-18
CRISPR Therapeutics AG. (4/13/17). "Press Release: CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics Announce Appeal of CRISPR/Cas9 U.S. Patent Board Decision". Basel, et al.. 2017-04-13
HiberGene Diagnostics Ltd.. (4/12/17). "Press Release: HiberGene Closes €6.7m Series B Funding Round". Dublin. 2017-04-12
Endo International plc. (4/12/17). "Press Release: Endo International plc Announces Pricing of Private Offering of Senior Secured Notes". Dublin. 2017-04-12
Sygnis AG. (4/11/17). "Press Release: Sygnis AG Successfully Completes Integration of Recently Acquired C.B.S. Scientific". Madrid & Heidelberg. 2017-04-11
Optibrium Ltd.. (4/11/17). "Press Release: Lhasa and Optibrium Enter Research and Product Development Collaboration". Cambridge & Leeds. 2017-04-11
Consilium Strategic Communications Ltd.. (4/10/17). "Press Release: Consilium Strategic Communications and Westwicke Partners Enter into Joint Venture for Healthcare Focused US IR Advisory". London & Baltimore, MD. 2017-04-10
Adaptimmune Therapeutics plc. (4/10/17). "Press Release: Adaptimmune Therapeutics plc Announces Closing of $42 Million Registered Direct Offering". Philadeliphia, PA & Oxford. 2017-04-10
Endo International plc. (4/10/17). "Press Release: Endo International plc Announces Proposed Private Offering of Senior Secured Notes". Dublin. 2017-04-10
Microsaic Systems plc. (4/7/17). "Press Release: Microsaic Signs Amended Agreement with Global Partner". 2017-04-07
Pirbright Institute, The. (4/7/17). "Press Release: Dr. Bryan Charleston Appointed as Director of The Pirbright Institute". 2017-04-07
MGB Biopharma Ltd.. (4/6/17). "Press Release: MGB Biopharma Closes $1 Million Financing Round to Finance Manufacturing of MGB-BP-3 for Phase II Study in Clostridium difficile-Associated Disease (CDAD)". Glasgow. 2017-04-06
bioMérieux S.A.. (4/6/17). "Press Release: bioMérieux Receives FDA 510(k) Clearance for its BacT/Alert VIRTUO Fully Automated Blood Culture System". Marcy l’Étoile. 2017-04-06
Novacyt S.A.. (4/6/17). "Press Release: Novacyt Announces Bond Issue". Paris & Cambridge. 2017-04-06
Adaptimmune Therapeutics plc. (4/5/17). "Press Release: Adaptimmune Therapeutics plc Announces Registered Direct Offering of American Depositary Shares". Philadeliphia, PA & Oxford. 2017-04-05
Heptares Therapeutics Ltd.. (4/5/17). "Press Release: Heptares to Receive US$12 Million Milestone Payment from AstraZeneca". London. 2017-04-05
SkinBioTherapeutics plc. (4/5/17). "Press Release: First Day of Dealings. Company to Trade under Ticker Code SBTX [Not for US, AU, CA, JP, ZA, IE, et al.]". Manchester. 2017-04-05
Nightstar Therapeutics plc. (4/4/17). "Press Release: NightstaRx Appoints Healthcare Finance Leader Senthil Sundaram as Chief Financial Officer". Boston, MA. 2017-04-04
Bicycle Therapeutics Ltd.. (4/3/17). "Press Release: Bicycle Therapeutics Announces Presentations at the 2017 American Association for Cancer Research Annual Meeting". Cambridge, MA & Cambridge. 2017-04-03
Cellnovo. (4/3/17). "Press Release: Cellnovo Appoints Erwan Martin as Chief Financial Officer". Paris. 2017-04-03
AstraZeneca plc. (3/31/17). "Press Release: Tagrisso (osimertinib) Receives US FDA Full Approval". 2017-03-31
Oxford BioMedica plc. (3/30/17). "Press Release: Oxford BioMedica Notes Acceptance by FDA of a Biologics License Application (BLA) Filing for CTL019". Oxford. 2017-03-30
Genomics Medicine Ireland Ltd.. (3/30/17). "Press Release: Genomics Medicine Ireland Announces Two Appointments to Its Board. Dr. Kari Stefánsson and Dr. Paul Saunders Appointed to the Board". Dublin. 2017-03-30
CARB-X. (3/30/17). "Press Release: CARB-X injects up to $48 million to accelerate first Powered by CARB-X portfolio of drug discovery and development projects to tackle antibiotic resistance". Washington, DC & London. 2017-03-30
Redx Pharma plc. (3/30/17). "Press Release: Redx Pharma Awarded US$1 Million Grant by CARB-X". 2017-03-30
Forge Therapeutics, Inc.. (3/30/17). "Press Release: Forge Therapeutics Wins Powered by CARB-X Research Award of $8.8M to Accelerate Development of its LpxC Antibiotic to Kill the World's Deadliest 'Superbugs'". San Diego, CA. 2017-03-30
Novartis AG. (3/29/17). "Press Release: Novartis Announces First CAR-T Cell Therapy BLA for Pediatric and Young Adult Patients with r/r B-cell ALL Granted FDA Priority Review". Basel. 2017-03-29
Biotest AG. (3/29/17). "Press Release: Discussions Regarding Possible Business Combination". Dreieich. 2017-03-29
Evotec AG. (3/28/17). "Press Release: Evotec Fiscal Year Results 2016. Leading Innovation Efficiency and First-in-class Drug Discovery". Hamburg. 2017-03-28
CRISPR Therapeutics AG. (3/28/17). "Press Release: CRISPR Therapeutics Announces European Patent for CRISPR/Cas Gene Editing". Basel. 2017-03-28
Linguamatics Ltd.. (3/28/17). "Press Relase: Linguamatics and Dow Jones Partner to Accelerate Pharma Industry Research". Cambridge & Boston, MA. 2017-03-28
InSphero AG. (3/27/17). "Press Release: InSphero 3D Liver Microtissues Featured at Annual SOT Meeting as More Sensitive Model for DILI and Mechanistic Toxicity Testing". Schlieren. 2017-03-27
Cosmo Pharmaceuticals N.V.. (3/27/17). "Press Release: Cosmo Announces further Expansion of Endoscopy Pipeline with Filing for EU Approval of New Medical Device Qolotag to Enhance Diagnosis in Sigmoidoscopies". Dublin. 2017-03-27
Adaptimmune Therapeutics plc. (3/27/17). "Press Release: Adaptimmune Therapeutics plc Announces Closing of Public Offering and Exercise of Underwriters’ Option to Purchase Additional American Depositary Shares". Philadeliphia, PA & Oxford. 2017-03-27
Adaptimmune Therapeutics plc. (3/27/17). "Press Release: Adaptimmune to Participate in Upcoming Jefferies Immuno-Oncology Summit". Philadeliphia, PA & Oxford. 2017-03-27
Cancer Research UK. (3/24/17). "Press Release: New Era in Precision Medicine for Pancreatic Cancer". 2017-03-24
PureTech Health plc. (3/24/17). "Press Release: PureTech Health Announces Licensing and Equity Agreement with Novartis to Advance Clinical Stage mTORC1 Programs". Boston, MA. 2017-03-24
BioLineRx Ltd.. (3/23/17). "Press Release: BioLineRx Announces Acquisition of Agalimmune Ltd. to Accelerate Expansion of Immuno-Oncology Pipeline". Tel Aviv. 2017-03-23
Numares AG. (3/23/17). "Press Release: Numares AG and Oxford University to Collaborate on Development of Multiple Sclerosis Diagnostic Test". Regensburg & Oxford. 2017-03-23
Unit DX. (3/23/17). "Press Release: Our Opening Event. The future looks bright for Science in Bristol". 2017-03-23
Regeneron Pharmaceuticals, Inc.. (3/22/17). "Press Release: U.K. Biobank, Regeneron and GSK Announce Largest Gene Sequencing Initiative on World's Most Detailed Health Database to Improve Drug Discovery and Disease Diagnosis". Tarrytown, NY. 2017-03-22
Adaptimmune Therapeutics plc. (3/22/17). "Press Release: Adaptimmune Therapeutics plc Prices Public Offering of American Depositary Shares". Philadeliphia, PA & Oxford. 2017-03-22
Microsaic Systems plc. (3/21/17). "Press Release: Audited Financial Results for the Year Ended 31 December 2016". 2017-03-21
Adaptimmune Therapeutics plc. (3/21/17). "Press Release: Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares". Philadeliphia, PA & Oxford. 2017-03-21
OptiBiotix Health plc. (3/21/17). "Press Release: Intention to Float SkinBioTherapeutics". 2017-03-21
Thermo Fisher Scientific Inc.. (3/21/17). "Press Release: Thermo Fisher Scientific and the Cell and Gene Therapy Catapult Collaborate to Optimise Advanced Therapy Supply Chain". London. 2017-03-21
Redx Pharma plc. (3/21/17). "Press Release: Final Results for the Year Ended 30 September 2016". 2017-03-21
Pulmocide Ltd.. (3/20/17). "Press Release: Pulmocide Raises $30 Million in Series B Financing. Funding to Progress Novel Wholly-owned Compounds for RSV and Pulmonary Aspergillosis". London. 2017-03-20
GlaxoSmithKline GmbH & Co. KG. (3/20/17). "Pressemitteilung: Spatenstich bei GSK in Marburg für eine 162 Mio € Meningokokken-B-Impfstoff-Produktion". 2017-03-20
Eurofins Scientific UK. (3/17/17). "Press Release: Eurofins to Invest Millions in New UK Facility". 2017-03-17
AstraZeneca plc. (3/17/17). "Press Release: AstraZeneca Receives Complete Response Letter from US FDA for ZS-9 (sodium zirconium cyclosilicate) for Hyperkalaemia". 2017-03-17
AstraZeneca plc. (3/17/17). "Press Release: AstraZeneca and Circassia Enter Strategic Collaboration in Respiratory Disease". 2017-03-17
Cell Medica Ltd.. (3/16/17). "Press Release: £60 Million Series C Financing to Advance Multiple Cancer Programmes". London. 2017-03-16
Adaptimmune Therapeutics plc. (3/15/17). "Press Release: Adaptimmune Broadens Executive Team". Philadeliphia, PA & Oxford. 2017-03-15
Waters Corporation. (3/15/17). "Press Release: Waters Now Offers Proteolabels Software. Product Extends the Functionality of Progenesis QI for Proteomics Applications". Milford, MA. 2017-03-15
Coulter Partners. (3/15/17). "Press Release: Coulter Partners Announces Further Swiss Expansion with New Office in Zurich". 2017-03-15
AstraZeneca plc. (3/14/17). "Press Release: Lynparza Phase III SOLO-2 Data Demonstrate Progression-free Survival Benefit in BRCA-mutated Ovarian Cancer as Maintenance Therapy". 2017-03-14
Editas Medicine, Inc.. (3/14/17). "Press Release: Allergan and Editas Medicine Enter into Strategic R&D Alliance to Discover and Develop CRISPR Genome Editing Medicines for Eye Diseases". Dublin & Cambridge, MA. 2017-03-14
Definiens AG. (3/13/17). "Press Release: NeoGenomics and Definiens Enter into Agreement to Develop Novel Assays for Clinical Trials & Clinical Testing". Fort Myers, FL. 2017-03-13
Adaptimmune Therapeutics plc. (3/13/17). "Press Release: Adaptimmune Reports Fourth Quarter and Full Year 2016 Financial Results". Philadeliphia, PA & Oxford. 2017-03-13
Heptares Therapeutics Ltd.. (3/13/17). "Press Release: Heptares Enters Agreement with Daiichi Sankyo to Discover and Develop Novel, Small Molecules for the Treatment of Pain". London. 2017-03-13
Sartorius AG. (3/9/17). "Press Release: Sartorius Appoints Gerry MacKay as Executive Vice President of Marketing, Sales and Services for Its Laboratory Division". Göttingen. 2017-03-09
Spero Therapeutics, LLC. (3/8/17). "Press Release: Spero Therapeutics Secures $51.7 Million in Oversubscribed Series C Financing". Cambridge, MA. 2017-03-08
ChemAxon Kft.. (3/8/17). "Press Release: ChemAxon Contributing to European Lead Factory’s Success". Budapest, Brussels & Utrecht. 2017-03-08
University of Sheffield. (3/7/17). "Press Release: Keapstone Therapeutics Launched in World-first Partnership to Develop New Drugs for Parkinson’s". 2017-03-07
Thermo Fisher Scientific Inc.. (3/7/17). "Press Release: Thermo Fisher Scientific Prices Offering of Euro-Denominated Senior Notes". Waltham, MA. 2017-03-07
Servier. (3/6/17). "Press Release: Vernalis plc and Servier Enter into a New Drug Discovery Collaboration Strengthening Their Existing Partnership". 2017-03-06
GlaxoSmithKline plc. (3/6/17). "Press Release: GSK’s MUSCA Study Shows Nucala (mepolizumab) Significantly Improves Quality of Life and Lung Function in Severe Asthma Patients with an Eosinophilic Phenotype". London. 2017-03-06
Prothena Corporation plc. (3/3/17). "Press Release: Prothena Announces Pricing of Public Offering of 2,700,000 Ordinary Shares". Dublin. 2017-03-03
Sartorius AG. (3/3/17). "Press Release: Sartorius to Acquire Real-time Live-cell Analysis Pioneer and Leader Essen BioScience". Göttingen. 2017-03-03
Sanofi S.A.. (3/3/17). "Press Release: Sanofi Pasteur and MedImmune Collaborate on Monoclonal Antibody to Prevent Illnesses Associated with RSV". Paris. 2017-03-03
Prothena Corporation plc. (3/2/17). "Press Release: Prothena Announces Public Offering of Ordinary Shares". Dublin. 2017-03-02
Merck KGaA. (3/2/17). "Press Release: NICE Expands Positive Recommendation for Erbitux as First-line Treatment for RAS Wild-type mCRC". Darmstadt. 2017-03-02
Adaptimmune Therapeutics plc. (3/2/17). "Press Release: Adaptimmune to Present at the Cowen and Company 37th Annual Health Care Conference". Philadeliphia, PA & Oxford. 2017-03-02
Newron Pharmaceuticals S.p.A.. (3/2/17). "Press Release: Newron Announces 2016 Financial Results and Provides Outlook for 2017". Milan. 2017-03-02
PureTech Health plc. (3/2/17). "Press Release: PureTech Health Appoints Bharatt Chowrira, Ph.D., J.D., as President and Chief of Business and Strategy". Boston, MA. 2017-03-02
Bicycle Therapeutics Ltd.. (3/2/17). "Press Release: Bicycle Therapeutics to Present at Cowen and Company 37th Annual Health Care Conference". Cambridge, MA & Cambridge. 2017-03-02
Adaptimmune Therapeutics plc. (3/1/17). "Press Release: Adaptimmune Cuts Ribbon on U.S. Headquarters at the Navy Yard in Philadelphia". Philadeliphia, PA & Oxford. 2017-03-01
Sygnis AG. (3/1/17). "Press Release: Sygnis AG Announces Management Changes. David Roth Appointed Chief Financial Officer (CFO) ". Madrid & Heidelberg. 2017-03-01
Arquer Diagnostics Ltd.. (3/1/17). "Press Release: Arquer Diagnostics Awarded Funding Under Innovate UK’s Biocatalyst Programme". Sunderland. 2017-03-01
Grail, Inc.. (3/1/17). "Press Release: GRAIL Closes Over $900 Million Initial Investment in Series B Financing to Develop Blood Tests to Detect Cancer Early". Menlo Park, CA. 2017-03-01
Faron Pharmaceuticals Oy. (3/1/17). "Press Release: Results of Placing and Subscription and Issue of Equity. Successful over-subscribed fundraising of £5.0 million through a Placing and Subscription [Not for United States, Australia, Canada, Japan, et al 2017-03-01
GlaxoSmithKline plc. (3/1/17). "Press Release: GSK Confirms Closure of Agreement to Divest Anaesthesia Portfolio to Aspen". London. 2017-03-01
Faron Pharmaceuticals Oy. (2/28/17). "Press Release: Proposed Placing and Subscription to Raise Up to £5.0 Million [Not for United States, Australia, Canada, Japan, et al.]". Turku. 2017-02-28
AstraZeneca plc. (2/28/17). "Press Release: FDA Approves Once-daily Qtern (dapagliflozin and saxagliptin) Tablets for Adults with Type-2 Diabetes". 2017-02-28
Oxford BioMedica plc. (2/28/17). "Press Release: Appointment of New Chief Financial Officer". Oxford. 2017-02-28
Arrakis Therapeutics, Inc.. (2/27/17). "Press Release: Arrakis Therapeutics Announces $38 Million Series A Financing to Target RNA with Small-Molecule Medicines and Names Michael Gilman Chairman and CEO". Waltham, MA. 2017-02-27
MolMed S.p.A.. (2/27/17). "Press Release: MolMed and Rocket Pharma Establish a Collaboration Agreement in the Field of Gene Therapy for the Treatment of Fanconi Anemia". Milan. 2017-02-27
Congenica Ltd.. (2/27/17). "Press Release: Congenica Raises £8M ($10M) in Series B Financing Round to Drive International Expansion of Its Genome Analysis Business". Cambridge. 2017-02-27
Premaitha Health plc. (2/27/17). "Press Release: Completion of Yourgene Acquisition, Issue of Shares and Director Appointments". Manchester. 2017-02-27
AstraZeneca plc. (2/24/17). "Press Release: ZS-9 (sodium zirconium cyclosilicate) Receives Positive CHMP Opinion for the Treatment of Hyperkalaemia". 2017-02-24
Napp Pharmaceuticals Ltd.. (2/24/17). "Press Release: Napp Launches Truxima (rituximab), the First Biosimilar Monoclonal Antibody for the Treatment of Cancer, in the UK". Cambridge. 2017-02-24
next pagenext page 1 2 3 ... 8 9 10 ... 41 42 43  next pagenext page



Advertisement

Picture BioM Forum Translational Medicine 2018 Würzburg Germany iito 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture BioM Forum Translational Medicine 2018 Würzburg Germany iito 600x60px

» top